SEC 13F Intelligence

Monashee Investment Management LLC / GPCR

Monashee Investment Management LLC’s Structure Therapeutics Inc Position

Does Monashee Investment Management LLC own Structure Therapeutics Inc (GPCR)? Yes50.0K shares worth $2M (+1.31% of its 13F portfolio) as of Q1 2026, down from 225.0K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
50.0K
% of Portfolio
+1.31%
Quarters Held
13
currently held

Position History GPCR

Reported value by quarter
Q1 ’23: $4MQ1 ’23Q2 ’23: $23MQ3 ’23: $32MQ3 ’23Q4 ’23: $8MQ1 ’24: $4MQ1 ’24Q2 ’24: $2MQ3 ’24: $7MQ3 ’24Q4 ’24: $4MQ1 ’25: $5MQ1 ’25Q2 ’25: $9MQ3 ’25: $6MQ3 ’25Q4 ’25: $16MQ1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202650.0K$2M+1.31%
Q4 2025225.0K$16M+8.82%
Q3 2025200.0K$6M+2.79%
Q2 2025430.0K$9M+3.23%
Q1 2025292.9K$5M+0.60%
Q4 2024132.0K$4M+0.49%
Q3 2024159.6K$7M+0.76%
Q2 202450.0K$2M+0.25%
Q1 202494.7K$4M+0.48%
Q4 2023191.9K$8M+1.38%
Q3 2023633.8K$32M+13.35%
Q2 20231.37M$23M+5.43%
Q1 2023170.0K$4M+1.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Monashee Investment Management LLC’s full portfolio or all institutional holders of GPCR.